Atrial Fibrillation and Cardiovascular Outcomes in the Elderly

PACE - Pacing and Clinical Electrophysiology

Volumn 39, Issue 9, 2016, Pages 907-913

  O'neal, Wesley T ^a   Salahuddin, Taufiq ^b   Broughton, Stephen T ^b   Soliman, Elsayed Z ^b  

^a EMORY UNIVERSITY SCHOOL OF MEDICINE   (United States)

^b WAKE FOREST SCHOOL OF MEDICINE   (United States)

Author keywords

atrial fibrillation; epidemiology; outcomes

Indexed keywords

AGED; ARTICLE; ATRIAL FIBRILLATION; BRAIN ISCHEMIA; CARDIOVASCULAR DISEASE; CARDIOVASCULAR RISK; CAUCASIAN; CLINICAL STUDY; COHORT ANALYSIS; CONTROLLED STUDY; DISEASE ASSOCIATION; FEMALE; FOLLOW UP; GERIATRICS; HAZARD RATIO; HEART FAILURE; HEART INFARCTION; HUMAN; INCIDENCE; ISCHEMIC HEART DISEASE; KAPLAN MEIER METHOD; MAJOR CLINICAL STUDY; MALE; MATHEMATICAL ANALYSIS; POPULATION RESEARCH; PROPORTIONAL HAZARDS MODEL; TIME; VERY ELDERLY;

EID: 84987723090     PISSN: 01478389     EISSN: 15408159     Source Type: Journal    
DOI: 10.1111/pace.12907     Document Type: Article

References (33)

1. Go AS, Hylek EM, Phillips KA, Chang Y, Henault LE, Selby JV, Singer DE. Prevalence of diagnosed atrial fibrillation in adults: National implications for rhythm management and stroke prevention: The AnTicoagulation and Risk Factors in Atrial Fibrillation (ATRIA) Study. JAMA 2001; 285:2370–2375.
2. Kim MH, Johnston SS, Chu BC, Dalal MR, Schulman KL. Estimation of total incremental health care costs in patients with atrial fibrillation in the United States. Circ Cardiovasc Qual Outcomes 2011; 4:313–320.
3. Krahn AD, Manfreda J, Tate RB, Mathewson FA, Cuddy TE. The natural history of atrial fibrillation: Incidence, risk factors, and prognosis in the Manitoba Follow-Up Study. Am J Med 1995; 98:476–484.
4. Benjamin EJ, Wolf PA, D'Agostino RB, Silbershatz H, Kannel WB, Levy D. Impact of atrial fibrillation on the risk of death: The Framingham Heart Study. Circulation 1998; 98:946–952.
5. Stewart S, Hart CL, Hole DJ, McMurray JJ. A population-based study of the long-term risks associated with atrial fibrillation: 20-Year follow-up of the Renfrew/Paisley study. Am J Med 2002; 113:359–364.
6. Conen D, Chae CU, Glynn RJ, Tedrow UB, Everett BM, Buring JE, Albert CM. Risk of death and cardiovascular events in initially healthy women with new-onset atrial fibrillation. JAMA 2011; 305:2080–2087.
7. Chamberlain AM, Gersh BJ, Alonso A, Chen LY, Berardi C, Manemann SM, Killian JM, et al. Decade-long trends in atrial fibrillation incidence and survival: A community study. Am J Med 2015; 128:260–267.
8. Schnabel RB, Yin X, Gona P, Larson MG, Beiser AS, McManus DD, Newton-Cheh C, et al. 50 Year trends in atrial fibrillation prevalence, incidence, risk factors, and mortality in the Framingham Heart Study: A cohort study. Lancet 2015; 386:154–162.
9. O'Neal WT, Efird JT, Judd SE, McClure LA, Howard VJ, Howard G, Soliman EZ. Impact of awareness and patterns of nonhospitalized atrial fibrillation on the risk of mortality: The Reasons for Geographic And Racial Differences in Stroke (REGARDS) Study. Clin Cardiol 2016; 39:103–110.
10. Wolf PA, Abbott RD, Kannel WB. Atrial fibrillation as an independent risk factor for stroke: The Framingham Study. Stroke 1991; 22:983–988.
11. Wang TJ, Larson MG, Levy D, Vasan RS, Leip EP, Wolf PA, D'Agostino RB, et al. Temporal relations of atrial fibrillation and congestive heart failure and their joint influence on mortality: The Framingham Heart Study. Circulation 2003; 107:2920–2925.
12. O'Neal WT, Qureshi W, Zhang ZM, Soliman EZ. Bidirectional association between atrial fibrillation and congestive heart failure in the elderly. J Cardiovasc Med (Hagerstown) 2016; 17:181–186.
13. Soliman EZ, Safford MM, Muntner P, Khodneva Y, Dawood FZ, Zakai NA, Thacker EL, et al. Atrial fibrillation and the risk of myocardial infarction. JAMA Intern Med 2014; 174:107–114.
14. O'Neal WT, Sangal K, Zhang ZM, Soliman EZ. Atrial fibrillation and incident myocardial infarction in the elderly. Clin Cardiol 2014; 37:750–755.
15. Soliman EZ, Lopez F, O'Neal WT, Chen LY, Bengtson L, Zhang ZM, Loehr L, et al. Atrial Fibrillation and risk of ST-segment-elevation versus non-ST-segment-elevation myocardial infarction: The Atherosclerosis Risk in Communities (ARIC) Study. Circulation 2015; 131:1843–1850.
16. Benjamin EJ, Levy D, Vaziri SM, D'Agostino RB, Belanger AJ, Wolf PA. Independent risk factors for atrial fibrillation in a population-based cohort. The Framingham Heart Study. JAMA 1994; 271:840–844.
17. O'Neal WT, Almahmoud MF, Soliman EZ. Resting heart rate and incident atrial fibrillation in the elderly. Pacing Clin Electrophysiol 2015; 38:591–597.
18. O'Neal WT, Qureshi WT, Blaha MJ, Keteyian SJ, Brawner CA, Al-Mallah MH. Systolic blood pressure response during exercise stress testing: The Henry Ford ExercIse Testing (FIT) Project. J Am Heart Assoc 2015; 4:e002050.
19. O'Neal WT, Efird JT, Yeboah J, Nazarian S, Alonso A, Heckbert SR, Soliman EZ. Brachial flow-mediated dilation and incident atrial fibrillation: The multi-ethnic study of atherosclerosis. Arterioscler Thromb Vasc Biol 2014; 34:2717–2720.
20. O'Neal WT, Soliman EZ, Howard G, Howard VJ, Safford MM, Cushman M, Zakai NA. Inflammation and hemostasis in atrial fibrillation and coronary heart disease: The REasons for Geographic And Racial Differences in Stroke study. Atherosclerosis 2015; 243:192–197.
21. Piccini JP, Hammill BG, Sinner MF, Hernandez AF, Walkey AJ, Benjamin EJ, Curtis LH, et al. Clinical course of atrial fibrillation in older adults: The importance of cardiovascular events beyond stroke. Eur Heart J 2014; 35:250–256.
22. Odden MC, Coxson PG, Moran A, Lightwood JM, Goldman L, Bibbins-Domingo K. The impact of the aging population on coronary heart disease in the United States. Am J Med 2011; 124:827–833.
23. Fried LP, Borhani NO, Enright P, Furberg CD, Gardin JM, Kronmal RA, Kuller LH, et al. The Cardiovascular Health Study: Design and rationale. Ann Epidemiol 1991; 1:263–276.
24. Psaty BM, Kuller LH, Bild D, Burke GL, Kittner SJ, Mittelmark M, Price TR, et al. Methods of assessing prevalent cardiovascular disease in the Cardiovascular Health Study. Ann Epidemiol 1995; 5:270–277.
25. Ives DG, Fitzpatrick AL, Bild DE, Psaty BM, Kuller LH, Crowley PM, Cruise RG, et al. Surveillance and ascertainment of cardiovascular events. The Cardiovascular Health Study. Ann Epidemiol 1995; 5:278–285.
26. Price TR, Psaty B, O'Leary D, Burke G, Gardin J. Assessment of cerebrovascular disease in the Cardiovascular Health Study. Ann Epidemiol 1993; 3:504–507.
27. Gray RJ, Tsiatis AA. A linear rank test for use when the main interest is in differences in cure rates. Biometrics 1989; 45:899–904.
28. Miyasaka Y, Barnes ME, Bailey KR, Cha SS, Gersh BJ, Seward JB, Tsang TS. Mortality trends in patients diagnosed with first atrial fibrillation: A 21-year community-based study. J Am Coll Cardiol 2007; 49:986–992.
29. Murdoch DR, Love MP, Robb SD, McDonagh TA, Davie AP, Ford I, Capewell S, et al. Importance of heart failure as a cause of death. Changing contribution to overall mortality and coronary heart disease mortality in Scotland 1979-1992. Eur Heart J 1998; 19:1829–1835.
30. Gupta S, Figueredo VM. Tachycardia mediated cardiomyopathy: Pathophysiology, mechanisms, clinical features and management. Int J Cardiol 2014; 172:40–46.
31. Aviles RJ, Martin DO, Apperson-Hansen C, Houghtaling PL, Rautaharju P, Kronmal RA, Tracy RP, et al. Inflammation as a risk factor for atrial fibrillation. Circulation 2003; 108:3006–3010.
32. Danesh J, Wheeler JG, Hirschfield GM, Eda S, Eiriksdottir G, Rumley A, Lowe GD, et al. C-reactive protein and other circulating markers of inflammation in the prediction of coronary heart disease. N Engl J Med 2004; 350:1387–1397.
33. Vasan RS, Sullivan LM, Roubenoff R, Dinarello CA, Harris T, Benjamin EJ, Sawyer DB, et al. Inflammatory markers and risk of heart failure in elderly subjects without prior myocardial infarction: The Framingham Heart Study. Circulation 2003; 107:1486–1491.